Medicine Description apixatrack 2.5 mg
apixatrack 2.5 mg tablets is a medication that functions as a direct oral anticoagulant (DOAC). It primarily acts by selectively inhibiting factor Xa, an essential enzyme in the coagulation cascade that leads to thrombin generation and subsequent clot formation. By binding to factor Xa, apixaban prevents the conversion of prothrombin to thrombin, thereby inhibiting the formation of fibrin and the development of a stable blood clot. This mechanism effectively reduces the risk of thromboembolic events, allowing for improved blood flow and reduced complications associated with clotting disorders.
Indications and Uses of apixatrack 2.5 mg tablets
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of recurrence of DVT and PE after initial therapy.
- Prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery.
Side Effects of apixatrack 2.5 mg tablets
- Bleeding complications, including gastrointestinal bleeding and hemorrhagic stroke.
- Bruising or increased tendency to bleed.
- Nausea and vomiting.
- Fatigue or weakness.
- Allergic reactions, such as rash or itching.
Storage and Handling
Store apixatrack 2.5 mg tablets at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Patient Advice and Precautions
Patients should be advised to report any signs of unusual bleeding or bruising to their healthcare provider promptly. It is important to inform healthcare professionals about all medications being taken to avoid potential interactions. Patients should avoid activities that may increase the risk of injury while on anticoagulation therapy.